Skip to main content

Table 1 Clinical characteristics of 13 pregnant women

From: Deleterious genetic variants in ciliopathy genes increase risk of ritodrine-induced cardiac and pulmonary side effects

Sample Maternal age (years) Gestational age at administration (weeks) Side effect(s)
S1 30–39 31.4 Dyspnea
S2 30–39 30.2 Pulmonary edema, Pulmonary congestion
S3 30–39 34.0 Tachycardia, Dyspnea
S4 30–39 35.1 Dyspnea
S5 20–29 35.4 Pulmonary edema, Dyspnea
S6 30–39 36.5 Tachycardia, Dyspnea
S7 30–39 15.2 Tachycardia, Dyspnea
S8 20–29 33.5 Dyspnea
S9 40–49 27.6 Tachycardia, Dyspnea, Palpitation
S10 20–29 20.3 Tachycardia, Dyspnea, Headache, Sweating
S11 20–29 30.6 Dyspnea, Palpitation
S12 20–29 30.5 Pulmonary edema
S13 40–49 32.2 Pulmonary edema